An opportunity to participate in a clinical research study that is essential for defining outcome measures for clinical trials by measuring how these conditions develop and progress. Without good clinical outcomes, effective clinical trials cannot be performed. Read more
Importance of Genetic Diagnosis
Since multiple forms of muscular dystrophy can have similar clinical symptoms, genetic analysis is the only definitive way to confirm your diagnosis of LGMD2B / Miyoshi. The Jain Foundation can help you obtain this genetic analysis. Read more
About the Disease
LGMD2B/Miyoshi Myopathy (collectively called dysferlinopathy) are rare forms of muscular dystrophy caused by mutations in the dysferlin gene. For the disease to occur both copies of the dysferlin gene must be defective (recessive inheritance). Read more
The Jain Foundation is happy to share a recent article from Stanford showcasing Tom Rando’s fantastic leadership and Katie Maguire’s work to develop an exciting new mouse model.